Pfizer COVID-19 vaccine 95% effective in tests, ready to seek emergency clearance

Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus.

"Primary efficacy analysis demonstrates BNT162b2 to be...